Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.

Medshine Discovery Inc.

Shanghai Leado Pharmatech Co. Ltd.

Jinxia Lin

Shuhui Chen

Jian Li

Zhifei Fu

Fei Hong

Miaorong Luo

Zhiliang Chen

Jinming Huang

Yichao Zhuang

Zhiyi Luo

Haiying He

Wentao Wu

Zhigan Jiang

Zhixiang Li

Juan Yu

Jian Qin

Lingling Zhang

Xiaoping Zheng

Jinxiang Zeng

Longhui Gao

Limei Yang

Wenliang Lan

Liju Wang

Youxin Wang

Disclosed in the present invention are a crystal form of a TrkA inhibitor and a preparation method thereof, and an application thereof in preparation of drugs for treating diseases associated with pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.

Crystal form of pyrrolidinyl urea derivative and application thereof

The present invention disclosed a crystal form of pyrazine-2(1H)-ketone compound and a preparation method therefor. Specifically disclosed is a method for preparing a compound of formula (II) and a crystal form thereof. 

Crystal form D of pyrazine-2(1H)-ketone compound and preparation method therefor

Disclosed are a crystal form (I) as an inhibitor of ACC1 and ACC2, a preparation method therefor, and the use thereof in the preparation of a drug as an inhibitor of ACC1 and ACC2. 

Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof

Provided are preparation methods for the chemical compound represented by formula (I) and an intermediate thereof. 

Pyrazine-2(1H)-ketone compound preparation method

Growing community of inventors

Zhangzhou, China

Jinxia Lin